We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+6.62%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$296B
AUM Growth
+$22.5B
Cap. Flow
+$7.07B
Cap. Flow %
2.39%
Top 10 Hldgs %
14.04%
Holding
10,482
New
945
Increased
3,995
Reduced
3,455
Closed
1,657

Sector Composition

Rank Sector Weight
1 Technology 13.25%
2 Financials 6.72%
3 Healthcare 6.58%
4 Consumer Discretionary 5.35%
5 Industrials 4.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BFEB icon
6626
Innovator US Equity Buffer ETF February
BFEB
$258M
$36.5K ﹤0.01%
1,067
-1,723
-62% -$56.3K
AQMS icon
6627
Aqua Metals
AQMS
$9.53M
$36.4K ﹤0.01%
156
-39
-20% -$8.5K
IBHE
6628
DELISTED
iShares iBonds 2025 Term High Yield and Income ETF
IBHE
$36.4K ﹤0.01%
+1,584
New +$36.1K
ECHO
6629
EchoStar
ECHO
$25.3B
$36.3K ﹤0.01%
2,096
-24,516
-92% -$413K
CVM icon
6630
CEL-SCI Corp
CVM
$28.1M
$36.3K ﹤0.01%
503
+36
+8% +$2.62K
LAB icon
6631
Standard BioTools
LAB
$314M
$36.3K ﹤0.01%
18,790
+1,120
+6% +$2.21K
BZUN
6632
Baozun
BZUN
$169M
$36.2K ﹤0.01%
9,079
-49,129
-84% -$220K
XBIT icon
6633
XBiotech
XBIT
$69.5M
$36.2K ﹤0.01%
6,090
+1,057
+21% +$4.77K
WBIY icon
6634
WBI Power Factor High Dividend ETF
WBIY
$63.8M
$36.1K ﹤0.01%
+1,393
New +$35.9K
BSEP icon
6635
Innovator US Equity Buffer ETF September
BSEP
$216M
$36.1K ﹤0.01%
1,047
-1,027
-50% -$33.6K
ELP
6636
DELISTED
Companhia Paranaense de Energia (COPEL)
ELP
$35.8K ﹤0.01%
5,203
-500,003
-99% -$3.04M
FDIF icon
6637
Fidelity Disruptors ETF
FDIF
$105M
$35.8K ﹤0.01%
+1,438
New +$35.4K
CNCR
6638
DELISTED
ETF Series Solutions Trust Range Cancer Therapeutics ETF
CNCR
$35.7K ﹤0.01%
2,765
+1,283
+87% +$16.8K
DTCR icon
6639
Global X Data Center & Digital Infrastructure ETF
DTCR
$2.33B
$35.6K ﹤0.01%
2,617
-1,945
-43% -$25.3K
CWAN
6640
DELISTED
Clearwater Analytics
CWAN
$35.4K ﹤0.01%
2,230
-48,484
-96% -$765K
XUSP icon
6641
Innovator Uncapped Accelerated US Equity ETF
XUSP
$53M
$35.4K ﹤0.01%
+1,245
New +$33.2K
NDVG
6642
DELISTED
Nuveen Dividend Growth ETF
NDVG
$35.4K ﹤0.01%
1,343
+1,195
+807% +$30.3K
EEX
6643
DELISTED
Emerald Holding
EEX
$35.3K ﹤0.01%
8,605
+4,549
+112% +$17.2K
MDT icon
6644
CALL
Medtronic
MDT
$110B
$35.2K ﹤0.01%
400
-216,800
-100% -$18.7M
CRNT icon
6645
Ceragon Networks
CRNT
$202M
$35.1K ﹤0.01%
16,734
+1,999
+14% +$3.69K
ONCY
6646
Oncolytics Biotech
ONCY
$95.6M
$35K ﹤0.01%
13,454
+4,304
+47% +$7.15K
ABXB
6647
Abacus Flexible Bond Leaders ETF
ABXB
$1.91M
$34.9K ﹤0.01%
1,689
+1,660
+5,724% +$34.5K
MZZ icon
6648
ProShares UltraShort MidCap400
MZZ
$2.41M
$34.8K ﹤0.01%
2,435
+2,136
+714% +$34.1K
MOON
6649
DELISTED
Direxion Moonshot Innovators ETF
MOON
$34.8K ﹤0.01%
2,756
-16,506
-86% -$188K
CAN
6650
Canaan Creative
CAN
$145M
$34.8K ﹤0.01%
16,321
+5,733
+54% +$13.9K

Similar funds

UBS Group's Q2 2023 Portfolio in Review

As of Q2 2023, UBS Group held 10,482 positions worth $296B, up 8.2% from $274B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

UBS Group's Q2 2023 filing shows 945 new, 3,995 increased, 3,455 reduced and 1,657 closed positions. Its largest new stake was Global X Emerging Markets Great Consumer ETF: 1,048,148 shares worth $26.1M. The largest sale was UBS Group, an estimated $3.79B.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q2 2023 buy was Global X Emerging Markets Great Consumer ETF: 1,048,148 shares worth $26.1M.
  • UBS Group added most to State Street Financial Select Sector SPDR ETF in Q2 2023, an estimated $456M increase.
  • UBS Group's biggest Q2 2023 reduction was UBS Group, cutting an estimated $3.79B.
  • UBS Group fully exited DCP Midstream, LP in Q2 2023, selling an estimated $148M.
  • UBS Group's ten largest holdings make up 14% of its $296B portfolio in Q2 2023.
  • UBS Group opened 945 new positions and closed 1,657 in Q2 2023.
  • UBS Group's portfolio value rose 8.2% quarter-over-quarter to $296B.

Based on UBS Group's 13F filing for Q2 2023, filed 11 Aug 2023.